Bing Xia

664 total citations
51 papers, 505 citations indexed

About

Bing Xia is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Bing Xia has authored 51 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 10 papers in Molecular Biology. Recurrent topics in Bing Xia's work include Lymphoma Diagnosis and Treatment (10 papers), Multiple Myeloma Research and Treatments (6 papers) and Viral-associated cancers and disorders (5 papers). Bing Xia is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Multiple Myeloma Research and Treatments (6 papers) and Viral-associated cancers and disorders (5 papers). Bing Xia collaborates with scholars based in China, United States and Philippines. Bing Xia's co-authors include Yizhuo Zhang, Shi Sun, Mi Zhang, Man Chen, Hanqing Zhang, Feihua Wu, Shanqi Guo, Xiaoxiong Wu, Haifeng Zhao and Chen Tian and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Chemistry.

In The Last Decade

Bing Xia

47 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Xia China 13 219 127 89 70 69 51 505
Roberta R. Ruela-de-Sousa Brazil 11 382 1.7× 99 0.8× 59 0.7× 38 0.5× 47 0.7× 12 556
Mark Wade United States 13 314 1.4× 150 1.2× 42 0.5× 54 0.8× 98 1.4× 35 632
Sarah Mackenzie United States 12 408 1.9× 116 0.9× 52 0.6× 38 0.5× 56 0.8× 20 628
Namrata Rastogi India 14 379 1.7× 148 1.2× 85 1.0× 36 0.5× 97 1.4× 20 706
Haydar Çelik United States 13 232 1.1× 79 0.6× 39 0.4× 34 0.5× 56 0.8× 27 447
Sheila Prachand United States 9 328 1.5× 184 1.4× 52 0.6× 72 1.0× 46 0.7× 20 572
Soumyasri Das Gupta United States 12 360 1.6× 169 1.3× 105 1.2× 68 1.0× 35 0.5× 14 707
Lijia Chen China 15 527 2.4× 153 1.2× 78 0.9× 48 0.7× 94 1.4× 53 831
Eui‐Kyu Noh South Korea 13 213 1.0× 80 0.6× 150 1.7× 25 0.4× 96 1.4× 25 503
J. Todd Williams United States 6 219 1.0× 69 0.5× 70 0.8× 56 0.8× 67 1.0× 7 490

Countries citing papers authored by Bing Xia

Since Specialization
Citations

This map shows the geographic impact of Bing Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xia more than expected).

Fields of papers citing papers by Bing Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xia. The network helps show where Bing Xia may publish in the future.

Co-authorship network of co-authors of Bing Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Xia. A scholar is included among the top collaborators of Bing Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Xia. Bing Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Fuyun, et al.. (2025). Early one-stage posterior-only surgery for congenital cervicothoracic scoliosis in children: medium- and long-term follow-up. Frontiers in Surgery. 12. 1473800–1473800. 1 indexed citations
3.
Xu, Lixia, et al.. (2024). Predicting radiation pneumonitis in lung cancer: a EUD-based machine learning approach for volumetric modulated arc therapy patients. Frontiers in Oncology. 14. 1343170–1343170. 4 indexed citations
4.
Fu, Xian, et al.. (2021). Ultrasonic Sputter Desorption Mass Spectrometry Technique for Minimally Invasive Tissue Analysis. Analytical Chemistry. 93(30). 10502–10510. 3 indexed citations
5.
Tian, Yuan, Ce Shi, Yi Wang, et al.. (2021). Downregulation of FAPP2 gene induces cell autophagy and inhibits PI3K/AKT/mTOR pathway in T‐cell acute lymphoblastic leukemia. Hematological Oncology. 40(2). 249–257. 6 indexed citations
6.
Kazmierski, Wieslaw M., George M. Adjabeng, Richard M. Grimes, et al.. (2020). GSK2818713, a Novel Biphenylene Scaffold-Based Hepatitis C NS5A Replication Complex Inhibitor with Broad Genotype Coverage. Journal of Medicinal Chemistry. 63(8). 4155–4170. 7 indexed citations
7.
Gao, Mei Hua, N. Chin Lai, Tracy Guo, et al.. (2019). Urocortin 2 Gene Transfer Improves Glycemic Control and Reduces Retinopathy and Mortality in Murine Insulin Deficiency. Molecular Therapy — Methods & Clinical Development. 17. 220–233. 7 indexed citations
8.
Wang, Chaoyu, Bing Xia, Haifeng Zhao, et al.. (2017). High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin’s lymphoma in China. Annals of Hematology. 97(3). 453–457. 27 indexed citations
9.
Li, Xiadong, et al.. (2016). The application research about registration methods of 4D-CBCT in non-small cell lung cancer with SBRT. Zhonghua fangshe zhongliuxue zazhi. 25(1). 71–75. 1 indexed citations
11.
Xia, Bing. (2015). Coexpression ofMYCandBCL-2predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma. World Journal of Gastroenterology. 21(8). 2433–2433. 14 indexed citations
12.
Wen, Bing, et al.. (2014). Empirical study of trimetazidine on inflammation among myocardial ischemia reperfusion injury in rats. Zhonghua shiyan waike zazhi. 31(3). 597–599. 1 indexed citations
13.
Zhao, Haifeng, Le Zhang, Shanqi Guo, et al.. (2014). Downregulated expression of Dicer1 predicts inferior survival in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab. Medical Oncology. 31(10). 206–206. 4 indexed citations
14.
Xia, Bing, Chen Tian, Shanqi Guo, et al.. (2014). c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia. Leukemia Research. 39(1). 92–99. 67 indexed citations
15.
Li, Xiaowu, Bing Xia, Shanqi Guo, et al.. (2013). A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components. Annals of Hematology. 92(6). 807–815. 12 indexed citations
16.
Zhang, Yizhuo, Qing Guo, Haifeng Zhao, et al.. (2012). Expression of CXCR4 is an independent prognostic factor for overall survival and progression-free survival in patients with myelodysplastic syndrome. Medical Oncology. 30(1). 341–341. 8 indexed citations
17.
Zhang, Yizhuo, Dandan Zhao, Haifeng Zhao, et al.. (2012). Hypermethylation of SHP-1 promoter in patient with high-risk myelodysplastic syndrome and it predicts poor prognosis. Medical Oncology. 29(4). 2359–2363. 12 indexed citations
18.
Zhang, Mi, Man Chen, Hanqing Zhang, et al.. (2009). In vivo hypoglycemic effects of phenolics from the root bark of Morus alba. Fitoterapia. 80(8). 475–477. 91 indexed citations
19.
Xia, Bing, et al.. (2008). A phantom study of optimal threshold segmentation for target volume delineation in 18 F-FDG PET/CT image of lung cancer. 28(6). 407–410. 1 indexed citations
20.
Xia, Bing. (2007). Dynamic change of essential oil content and increment in different organs of Atractylodes lancea. Zhiwu ziyuan yu huanjing. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026